By MARILYNN MARCHIONE, AP Chief Medical Writer The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday for remdesivir, []
The post Gileads $2,340 Price For Coronavirus Drug Draws Criticism appeared first on Afro.